Alzheimer Disease
📧 Sign up to get email alerts when something new happens for Alzheimer Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2009-09-30Clinical Trial Update: Study Evaluating the Safety,Tolerability, PK and PD of SAM-531 in the Subjects With Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating SAM-531 for Alzheimer's disease has completed, focusing on safety, tolerability, pharmacokinetics and pharmacodynam…
-
CLINICAL_TRIALS trial_result · 2009-09-24Clinical Trial Update: Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease [Phase 2]
This Phase 2 randomized trial evaluated safety, tolerability, and pilot efficacy of AN-1792 in Alzheimer's disease, but the study was termin…
-
CLINICAL_TRIALS trial_result · 2009-09-23Clinical Trial Update: Pioglitazone in Alzheimer Disease [Phase 2]
A Phase 2 trial evaluating pioglitazone in Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-09-21Clinical Trial Update: A Study to Determine the Clinical Safety/Tolerability and Exploratory Efficacy of EHT 0202 as Adjunctive Therapy to Acetylcholinesterase Inhibitor in Mild to Moderate Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating the safety, tolerability, and exploratory efficacy of EHT 0202 as an adjunct to acetylcholinesterase inhibitors in …
-
CLINICAL_TRIALS trial_result · 2009-09-18Clinical Trial Update: Passport to Brain Wellness in Sedentary Adults [NA]
A completed clinical trial study focused on brain wellness in sedentary adults with mild cognitive impairment and Alzheimer's disease.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2009-09-04Clinical Trial Update: Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD) [Phase 2]
A Phase 2 study evaluating SRA-333 in mild-to-moderate Alzheimer's disease has completed. The sponsor Wyeth is now a wholly owned subsidiary…
-
CLINICAL_TRIALS trial_result · 2009-08-26Clinical Trial Update: Study Evaluating How Quickly And To What Extent The 14-Carbon-SAM-531 Is Absorbed/Converted/Eliminated In Male Subjects [Phase 1]
A completed Phase 1 pharmacokinetic study evaluating absorption, metabolism, and elimination of SAM-531 (14-Carbon-SAM-531) in male subjects…
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating the safety and memory effects of PYM50028 in individuals with mild Alzheimer's disease has been completed.
-
CLINICAL_TRIALS trial_result · 2009-08-21Clinical Trial Update: Evaluation of [123I] MNI-308 and SPECT as a Marker of Beta-amyloid Protein Deposition in AD Subjects Compared to HC [Phase 1]
Phase 1 trial evaluating [123I] MNI-308 with SPECT as a marker of beta-amyloid deposition in Alzheimer's disease subjects. The study status …
-
CLINICAL_TRIALS trial_result · 2009-08-20Clinical Trial Update: A Safety and Tolerability Evaluation of Two 10-Week Dose Regimens of Orally-Administered PF-04494700 in Alzheimer's Patients [Phase 2]
Phase 2 safety and tolerability evaluation of two 10-week oral dose regimens of PF-04494700 in patients with Alzheimer's disease. The study …
-
CLINICAL_TRIALS trial_result · 2009-08-07Clinical Trial Update: Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SAM-531 in Healthy Japanese Males [Phase 1]
A Phase 1 study evaluated the safety, tolerability, pharmacokinetics, and pharmacodynamics of SAM-531 in healthy Japanese male volunteers; t…
-
CLINICAL_TRIALS trial_result · 2009-08-04Clinical Trial Update: Study Evaluating PAZ-417 in Cerebrospinal Fluid in Subjects With Alzheimer's Disease [Phase 1]
Phase 1 study evaluating PAZ-417 in cerebrospinal fluid for Alzheimer's disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: Study Evaluating Safety, Tolerability and Pharmacokinetics of Single and Multiple Dose of SAM-531 [Phase 1]
Phase 1 study evaluating safety, tolerability and pharmacokinetics of single and multiple doses of SAM-531 in Alzheimer's disease; the study…
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: A Study of PRX-03140 in Subjects With Alzheimer's Disease Receiving a Stable Dose of Donepezil [Phase 2]
A Phase 2 study of PRX-03140 in Alzheimer's disease patients on a stable dose of Donepezil has been terminated.
-
CLINICAL_TRIALS trial_result · 2009-07-30Clinical Trial Update: Study of PRX-03140 Monotherapy in Subjects With Alzheimer's Disease [Phase 2]
Phase 2 study of PRX-03140 as monotherapy in Alzheimer's disease was terminated.
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Cholesterol Lowering Agent to Slow Progression (CLASP) of Alzheimer's Disease Study [Phase 3]
A Phase 3 clinical trial called CLASP evaluating a cholesterol-lowering agent for slowing progression of Alzheimer's disease has completed.
-
CLINICAL_TRIALS trial_result · 2009-07-28Clinical Trial Update: Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease [Phase 1]
Pfizer conducted a Phase 1 single-dose escalation study of PF-04360365 in adults with mild to moderate Alzheimer's disease; the trial status…
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Risk Evaluation and Education for Alzheimer's Disease [NA]
This clinical trial update from NHGRI reports the completion of a study on risk evaluation and education for Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2009-07-23Clinical Trial Update: Risk Evaluation and Education for Alzheimer's Disease (REVEAL) II
Completed update on the REVEAL II trial, a risk evaluation and education program for individuals with Alzheimer's disease.
-
CLINICAL_TRIALS trial_result · 2009-07-20Clinical Trial Update: Effect on Cognitive Performance and Safety/Tolerability of SSR180711C in Mild Alzheimer's Disease [Phase 2]
Phase 2 trial evaluating SSR180711C in mild Alzheimer's disease has been terminated according to the clinical trial update.
-
CLINICAL_TRIALS trial_result · 2009-07-15Clinical Trial Update: Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) [Phase 2]
A Phase 2 study evaluated adding rasagiline at 1 mg or 2 mg daily to donepezil (Aricept) 10 mg in patients with mild-to-moderate Alzheimer's…
-
CLINICAL_TRIALS trial_result · 2009-07-15Clinical Trial Update: A Safety Study of LY2811376 Single Doses in Healthy Subjects [Phase 1]
Phase 1 safety study evaluating a single dose of LY2811376 in healthy subjects, sponsored by Eli Lilly and Company, related to Alzheimer's d…
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Study Evaluating Safety of GSI 136 in Young and Elderly Japanese Males [Phase 1]
This Phase 1 safety study of GSI-136 in young and elderly Japanese males, including participants with Alzheimer's disease and healthy volunt…
-
CLINICAL_TRIALS trial_result · 2009-07-10Clinical Trial Update: Study Evaluating PAZ-417 in Healthy Young/Elderly
A clinical trial evaluating PAZ-417 in healthy young and elderly participants has completed, with Alzheimer's disease listed as the conditio…
-
CLINICAL_TRIALS trial_result · 2009-07-07Clinical Trial Update: Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of SAM-531 [Phase 1]
This document reports the completion of a Phase 1 study evaluating the safety, pharmacokinetics, and pharmacodynamics of SAM-531 in Alzheime…